U.S. Dialysis Services Market Size, Share & COVID-19 Impact Analysis, By Type (Hemodialy-sis, Peritoneal Dialysis), By End-user (Dialysis Center, Home Healthcare, Hospital) and Fore-cast, 2021-2028

The U.S. dialysis services market size was valued USD 25.87 billion in 2020 and is anticipated to grow from USD 26.20 billion in 2021 to USD 32.46 billion in 2028, exhibiting a CAGR of 3.11% in the 2021-2028 period. Based on our analysis, the market displayed a lower growth of 1.19% in 2020 as compared to the average year-on-year growth during 2017-2028. The impact of pandemic has been unprecedented and staggering, with the industry witnessing a negative impact on demand amidst the pandemic. The growth in CAGR is attributable to this market's demand and growth, returning to pre-pandemic  levels once the pandemic is over.

The population of patients receiving dialysis persists to grow speedily in the U.S. every year. As per the national kidney foundation, in 2018, 785,883 Americans had kidney failure, and 554,038 of these patients received dialysis. However, a significant number of people lack access to kidney replacement therapy, and millions of people die of kidney failure every year, often without supportive care. Furthermore, a shift in the trend of the adoption of telehealth-based treatments is projected to boost the market growth during the forecast period.

For example, in the U.S., the Bipartisan Budget Act (federal statute formed with regards to spending and budget in the U.S.) was signed into law and came into effect on 1 January 2019. Furthermore, this law extended telehealth access to home patients. Therefore, is likely to propel the demand during the projected timeframe.

COVID-19 Pandemic Enhanced Growth Backed by Availability of Virtual Platform in the U.S. Dialysis Service Market

Dialysis centers are closed or converted into COVID-19 facilities to cope with the increasing patient load. In the present scenario, numerous facilities providing care to patients with End-Stage Renal Disease (ESRD) faced challenges in safeguarding patients and staff while providing clinical care. However, many companies offering virtual healthcare services witnessed strong growth in their sales.

For instance, in 2020, Baxter International, a global innovator in renal care, had launched Peritoneal Dialysis Excellence Academy, a new virtual training platform and educational resource center to help nurses advance their skills to deliver optimal patient care in the U.S. With an increasing need and desire for virtual education because of the pandemic, the resources were designed to offer a standardized and actionable curriculum.

LATEST TRENDS

Request a Free sample to learn more about this report.

Technological Advancement in Telehealth to Increase Market Potentiality

Advancements in any market are optimistic in influencing the U.S. dialysis services industry's potentiality and market price. Telehealth and dialysis both foster greater home-based care, less time period, and fewer trips to the clinic. It also helps to facilitate patient education about home modalities and self-care. Nephrologists and dialysis providers have implemented telehealth platforms to deliver care for patients receiving treatment. Telehealth platforms varied from video conferencing alone to platforms that also grant for self-scheduling, payment collection, and physician notifications. For example, in 2020, Fresenius Medical Care North America rolled out the plan of a new telehealth solution mainly for home patients. The company has more than 2700 in-center and home facilities. Telehealth aims to continue the rapid climb of home therapies by improving collaboration among patients, the clinical care team, and physicians.

DRIVING FACTORS

Shift from Clinics to Home Healthcare Services to Propel Market Growth

Many patients with End-Stage Renal Disease (ESRD) shift from one kind of dialysis to another as per their routine. Some patients prefer to treat themselves at home, while others would rather have professionals treating them at clinics. It can be done at a speciality center or at home. However, there is a significant shift of patients from clinics to home healthcare as patients can dialyze from the ease of home.

Home hemodialysis has potential advantages over clinics or hospitals. Patients get the opportunity for more frequent and longer sessions. The adoption of home healthcare services helps to cope with the increasing numbers of people requiring treatment. For example, DaVita and Fresenius Medical Care offer two classes, one is hemodialysis that requires a machine and special filter, very similar to in clinics, and the other one is peritoneal.

Furthermore, Fresenius Medical Care is projecting to change some of the speciality clinics into 'transitional care units' to train people at home to boost the percentage of its U.S. customers using home care services by more than 15 percent in 2022. The company is also expanding in-home care with its acquisition of NxStage, a U.S. maker of home-use dialysis machines.

Rising Prevalence of Kidney Diseases in the United States to Boost Market Growth

The rise in the prevalence of end-stage renal diseases (ESRD) is increasing the demand for dialysis services in the U.S. as well as globally. With the current situation of the pandemic, the market is further estimated to grow due to the increased patient pool. For instance, according to National Health and Nutrition Examination Survey (NHANES), the prevalence of chronic kidney diseases (CKD) amongst U.S. adults is increasing. Nearly 15% of the adult population in the United States have chronic kidney diseases.

The factors responsible for the high prevalence of the disease in the include the aging population, diabetic people, hypertension, cardiovascular disease, and other conditions. Furthermore, according to reports published by The National Kidney Foundation (NKF) estimated that one in every three adults is at risk of kidney disease, and it is the leading cause of death in the United States.

RESTRAINING FACTORS

Surging Patient Pool Opting for Kidney Transplantation Procedure to Hamper Growth

Kidney transplantation is an alternative for patients suffering from End-Stage Renal Diseases (ESRD) and chronic kidney diseases. Advancement in surgical tools has made kidney transplantation easier. As per U.S. government information on Organ donation and transplantation, there were 39,000 transplants performed in 2020, of which 22,010 were kidney transplants. In 2020, a partnership between the U.S. department of health and human services (HHS) and the American Society of Nephrologist (ASN) had launched KidneyX – a Kidney accelerator innovation for the prevention, diagnosis, and treatment of kidney diseases. The better results associated with kidney transplant and affordability of procedures is projected to affect the growth in the U.S. dialysis services industry during the forecast period.

SEGMENTATION

By Dialysis Type Analysis

To know how our report can help streamline your business, Speak to Analyst

Increasing Prevalence of Hypertension and Diabetes to Drive This Segment

Based on dialysis type, the market is segmented into hemodialysis and peritoneal. The hemodialysis segment dominated the market and held the highest market revenue share in 2020. This segment is further divided into acute and chronic. The segmental dominance is attributable to the increase in the incidence of hypertension and diabetes. With reference to the Center for Disease Control and Prevention (CDC) report states that the prevalence of diabetes in 2020 is approximately 34 million in the United States. Furthermore, factor such as shortage in availability of kidneys for transplants is also likely to augment the growth of the market.

Furthermore, the increasing burden of acute and chronic renal disease, along with favorable reimbursement scenarios, chronic kidney diseases, and the growing number of end-stage renal disease (ESRD) patients, are anticipated to propel the expansion of the hemodialysis segment during the forecast period.

By End-user Analysis

Merger and Acquisition Activities by Foremost Players to Augment the Dialysis Center Segment

Based on the end-users, the market is segmented into dialysis centers, home healthcare, and hospitals. The dialysis center segment dominated the market in terms of share in 2020 and is expected to retain its position by the end of 2028. For example, DaVita and Fresenius medical care are experiencing M&A activities from private equity investors. In accordance with the report of the United States Renal Data system (USRDS), there are more than 7,500 centers in the U.S., of which DaVita has 2821 centers, and Fresenius has 2634 centers.

According to American renal Associates (ARA), a large-scale dialysis provider in the United States is focusing on joint ventures with nephrology physicians. ARA functions more than 240 dialysis clinics in partnership with around 400 nephrologist partners treating approximately 16,500 patients. Additionally, a rise in the facility visit is leading to the expansion of the segment.

KEY INDUSTRY PLAYERS

Expansion of Dialysis Services across the U.S. to Lead to Intense Competition among Industry Players

The market is consolidated with key major players providing services in the country. Among all the key players, DaVita Inc. represents a significant U.S. dialysis services market share owing to its widespread facilities across states. This company is one of the leading providers of kidney dialysis services and related lab services. It owns approximately 2,800 outpatient facilities in the United States and provides acute inpatient services at approximately 900 hospitals. Most of the company's dialysis services are provided at its outpatient hemodialysis centers. Additionally, the incorporation of telehealth technology by companies like DaVita and Baxter, with their focus on acquisitions & partnerships to provide services to a large population, is anticipated to increase the potential of the industry during the forecast period.

LIST OF KEY COMPANIES PROFILED:

• Fresenius Medical Care AG & Co. (Bad Homburg, Germany)


• DaVita Inc. (Denver, Colorado, United States)


• American Renal® Associates (Beverly, Massachusetts, United States)


• U.S. Renal Care, Inc.(  Plano, Texas, United States)


• Satellite Healthcare (San Jose, United States)


• Baxter (Illinois, United States)


• B. Braun Melsungen AG, (Melsungen, Germany)


• Becton, Dickinson, and Company (New Jersey, United States)


• DCI Inc. (Tennessee, United States)


• NxStage Medical, Inc. (Massachusetts, United States)


• Other Prominent Players

KEY INDUSTRY DEVELOPMENTS:

• June 2019 - Baxter International Inc. had commenced share source 2.0 clinical portal (a telehealth platform), which brings insights to patients for home peritoneal dialysis treatments. The methodology of remote patient management technology assisted the company in strengthening its customer base.


• October 2019 - Fresenius Medical Care ag co kgaa announced the acquisition NxStage Medical, Inc. (a U.S.-based home dialysis leader). This acquisition will help the company expand the manufacturing marketing and supply chain competencies across the market.

REPORT COVERAGE

An Infographic Representation of U.S. Dialysis Services Market

View Full Infographic

To get information on various segments, share your queries with us

The report offers an elaborative and competitive landscape analysis of numerous factors affecting the market. It focuses on crucial aspects such as leading companies, types, and end-users. Additionally, it offers insights into the U.S. dialysis services market trends and highlights dynamic industry developments. In addition to the factors mentioned above, the report comprehends various factors that have contributed to the market's growth over recent years. It analyzes many strategies such as product innovations, mergers, alliances, joint ventures, and acquisitions adopted by the industry players.

REPORT SCOPE & SEGMENTATION